Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial.
Sign Up to like & getrecommendations! Published in 2022 at "Cancer cell"
DOI: 10.1016/j.ccell.2022.02.007
Abstract: Platinum-based chemotherapy is the standard first-line treatment for advanced esophageal squamous cell carcinoma (ESCC). In this phase 3 study (ClinicalTrial.gov: NCT03829969), 514 patients with treatment-naïve advanced ESCC were randomized (1:1) to receive toripalimab or placebo… read more here.
Keywords: advanced esophageal; treatment advanced; treatment; esophageal squamous ... See more keywords